{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"atlas","updatedThrough":"2026-08-15","guardrail":"The atlas exposes only relationships declared in the current public data. A link or issue grouping does not make unlike measures comparable, establish ownership or control, define an antitrust market, assign liability, or show that a policy event caused an economic outcome.","filters":{"depth":1,"edgeType":"all","edgeTypeMatched":true,"focus":"source:ftc-pbm-interim-2024","focusMatched":true,"kind":"all","kindMatched":true,"layer":"all","layerMatched":true,"query":"","view":"network"},"summary":{"nodeCount":5478,"edgeCount":19193,"sourceCount":45,"profileCount":5433,"nodeKindCount":13,"layerCount":4,"eligibleEdgeCount":19193,"matchedNodeCount":5,"plottedEdgeCount":7,"plottedNodeCount":5,"hiddenNodeCount":0,"directNeighborCount":4},"focusNode":{"id":"source:ftc-pbm-interim-2024","kind":"source","label":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","shortLabel":"Federal Trade Commission","description":"FTC interim staff report and press release on PBM concentration and vertical integration.","href":"/sources/ftc-pbm-interim-2024","metricLabel":"Access date","metricValue":"2026-05-16","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-interim-2024 pharmacy benefit managers: the powerful middlemen inflating drug costs and squeezing main street pharmacies federal trade commission ftc interim staff report and press release on pbm concentration and vertical integration. federal trade commission, ftc releases interim staff report on prescription drug middlemen, july 9 2024. agency_report","connectionCount":4},"nodes":[{"id":"source:ftc-pbm-interim-2024","kind":"source","label":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","shortLabel":"Federal Trade Commission","description":"FTC interim staff report and press release on PBM concentration and vertical integration.","href":"/sources/ftc-pbm-interim-2024","metricLabel":"Access date","metricValue":"2026-05-16","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-interim-2024 pharmacy benefit managers: the powerful middlemen inflating drug costs and squeezing main street pharmacies federal trade commission ftc interim staff report and press release on pbm concentration and vertical integration. federal trade commission, ftc releases interim staff report on prescription drug middlemen, july 9 2024. agency_report","connectionCount":4,"distance":0,"labelVisible":true,"radius":20,"x":450,"y":260},{"id":"market:mkt-pbm","kind":"market","label":"U.S. pharmacy benefit management","shortLabel":"PBMs","description":"Pharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.","href":"/markets/us-pharmacy-benefit-management","metricLabel":"HHI status","metricValue":"Withheld","detail":"United States / 2023","status":"incomplete","year":2023,"color":"#14b8a6","searchText":"u.s. pharmacy benefit management pbms health care united states pharmacy benefit management services profile based on ftc public findings. the ftc reports top-three and top-six aggregate shares but not enough individual pbm market shares in the public press-release record to compute hhi.","connectionCount":10,"x":450,"y":112,"distance":1,"radius":11,"labelVisible":true},{"id":"policy_record:evt-pbm-interim-report-2024","kind":"policy_record","label":"FTC releases interim staff report on prescription drug middlemen","shortLabel":"FTC releases interim sta...","description":"The FTC published interim findings on PBM concentration and vertical integration, including aggregate shares for the largest PBMs.","href":"/enforcement/records/pbm-interim-report-2024","metricLabel":"Official stage","metricValue":"monitoring","detail":"Federal Trade Commission / 2024-07-09","status":"report","year":2024,"color":"#f43f5e","searchText":"evt-pbm-interim-report-2024 ftc releases interim staff report on prescription drug middlemen federal trade commission report monitoring the ftc published interim findings on pbm concentration and vertical integration, including aggregate shares for the largest pbms.","connectionCount":8,"x":598,"y":260,"distance":1,"radius":11,"labelVisible":true},{"id":"report:rep-us-competition-landscape-2026","kind":"report","label":"The U.S. Competition Landscape","shortLabel":"The U.S. Competition La...","description":"A national briefing that aligns defined-market signals, industry structure, state and local geographic concentration screens, merger activity, and enforcement records without collapsing their different scopes.","href":"/reports/us-competition-landscape-2026","metricLabel":"Evidence sources","metricValue":"14","detail":"8 linked markets","status":"published","year":2026,"color":"#6366f1","searchText":"the u.s. competition landscape state of competition 2026: five evidence systems, no single score a national briefing that aligns defined-market signals, industry structure, state and local geographic concentration screens, merger activity, and enforcement records without collapsing their different scopes. a source-backed state-of-competition briefing across markets, industries, state systems, local banking screens, mergers, and enforcement, with every system kept in its own analytical universe. 2022 and 2017 u.s. economic census industry concentration tables, usda ers historical meatpacking cr4, kff 2024 state individual-market hhi, fdic 2025 statewide and county summary of deposits screens, the fy2025 ftc/doj hsr report, and source-backed market and enforcement records.","connectionCount":26,"x":450,"y":408,"distance":1,"radius":11,"labelVisible":true},{"id":"report:rep-public-data-gaps","kind":"report","label":"Where Public Market-Share Data Runs Out","shortLabel":"Where Public Market-Sha...","description":"An open report explaining why the observatory sometimes withholds HHI even when public facts indicate concentration.","href":"/reports/public-data-gaps","metricLabel":"Evidence sources","metricValue":"2","detail":"2 linked markets","status":"published","year":2026,"color":"#6366f1","searchText":"where public market-share data runs out why incomplete profiles are part of the product an open report explaining why the observatory sometimes withholds hhi even when public facts indicate concentration. a transparency note on incomplete data and why the observatory never fills gaps with invented shares. bts public airline market-share table and ftc pbm interim staff report materials.","connectionCount":5,"x":302,"y":260,"distance":1,"radius":11,"labelVisible":true}],"rows":[{"id":"policy-scope:evt-pbm-interim-report-2024:mkt-pbm","layer":"enforcement","relationshipType":"policy_scope","relationshipLabel":"Related policy context","fromId":"market:mkt-pbm","fromKind":"market","fromLabel":"U.S. pharmacy benefit management","fromHref":"/markets/us-pharmacy-benefit-management","toId":"policy_record:evt-pbm-interim-report-2024","toKind":"policy_record","toLabel":"FTC releases interim staff report on prescription drug middlemen","toHref":"/enforcement/records/pbm-interim-report-2024","evidenceLabel":"Federal Trade Commission / 2024-07-09","evidenceDetail":"Supplies top-three and top-six concentration facts while leaving individual firm shares unavailable; Antitrust Radar therefore continues to withhold HHI.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A related-market edge records the observatory's bounded context for a dated official event; it does not show causal effects on concentration."},{"id":"record-source:evt-pbm-interim-report-2024:ftc-pbm-interim-2024","layer":"enforcement","relationshipType":"record_source","relationshipLabel":"Official record source","fromId":"policy_record:evt-pbm-interim-report-2024","fromKind":"policy_record","fromLabel":"FTC releases interim staff report on prescription drug middlemen","fromHref":"/enforcement/records/pbm-interim-report-2024","toId":"source:ftc-pbm-interim-2024","toKind":"source","toLabel":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","toHref":"/sources/ftc-pbm-interim-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies is the custody record encoded for this dated policy event.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"high","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"The source is the official custody record for the encoded event; later outcomes require separate evidence."},{"id":"market-source:mkt-pbm:ftc-pbm-interim-2024","layer":"measurement","relationshipType":"market_source","relationshipLabel":"Market evidence custody","fromId":"market:mkt-pbm","fromKind":"market","fromLabel":"U.S. pharmacy benefit management","fromHref":"/markets/us-pharmacy-benefit-management","toId":"source:ftc-pbm-interim-2024","toKind":"source","toLabel":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","toHref":"/sources/ftc-pbm-interim-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies supports the profile's definition, observation.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A source link identifies evidence used by a market profile and does not endorse every claim in the underlying record."},{"id":"report-market:rep-public-data-gaps:mkt-pbm","layer":"research","relationshipType":"report_market","relationshipLabel":"Covered market profile","fromId":"report:rep-public-data-gaps","fromKind":"report","fromLabel":"Where Public Market-Share Data Runs Out","fromHref":"/reports/public-data-gaps","toId":"market:mkt-pbm","toKind":"market","toLabel":"U.S. pharmacy benefit management","toHref":"/markets/us-pharmacy-benefit-management","evidenceLabel":"Report scope contract","evidenceDetail":"Where Public Market-Share Data Runs Out explicitly lists U.S. pharmacy benefit management in its related-market scope.","sourceId":null,"sourceUrl":null,"confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A publication link identifies an explicitly covered market profile and does not make separately defined markets interchangeable."},{"id":"report-market:rep-us-competition-landscape-2026:mkt-pbm","layer":"research","relationshipType":"report_market","relationshipLabel":"Covered market profile","fromId":"report:rep-us-competition-landscape-2026","fromKind":"report","fromLabel":"The U.S. Competition Landscape","fromHref":"/reports/us-competition-landscape-2026","toId":"market:mkt-pbm","toKind":"market","toLabel":"U.S. pharmacy benefit management","toHref":"/markets/us-pharmacy-benefit-management","evidenceLabel":"Report scope contract","evidenceDetail":"The U.S. Competition Landscape explicitly lists U.S. pharmacy benefit management in its related-market scope.","sourceId":null,"sourceUrl":null,"confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A publication link identifies an explicitly covered market profile and does not make separately defined markets interchangeable."},{"id":"report-source:rep-public-data-gaps:ftc-pbm-interim-2024","layer":"research","relationshipType":"report_source","relationshipLabel":"Declared publication source","fromId":"report:rep-public-data-gaps","fromKind":"report","fromLabel":"Where Public Market-Share Data Runs Out","fromHref":"/reports/public-data-gaps","toId":"source:ftc-pbm-interim-2024","toKind":"source","toLabel":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","toHref":"/sources/ftc-pbm-interim-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies appears in the report's encoded source basis.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A source edge records the public evidence basis declared by the publication and does not erase the source's limitations."},{"id":"report-source:rep-us-competition-landscape-2026:ftc-pbm-interim-2024","layer":"research","relationshipType":"report_source","relationshipLabel":"Declared publication source","fromId":"report:rep-us-competition-landscape-2026","fromKind":"report","fromLabel":"The U.S. Competition Landscape","fromHref":"/reports/us-competition-landscape-2026","toId":"source:ftc-pbm-interim-2024","toKind":"source","toLabel":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","toHref":"/sources/ftc-pbm-interim-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies appears in the report's encoded source basis.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A source edge records the public evidence basis declared by the publication and does not erase the source's limitations."}]}